Safety & Efficacy of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia (ATHENA II)
Clinical trial NCT02052427 · COMPLETED
Trial details
- NCT number
- NCT02052427
- Sponsor
- Cytori Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-08-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.